Hoang Van Tam, Parsad Davinder, Van Thuong Nguyen, Thi Phuong Hoang, Hong Son Nguyen, Thu Hien Do Thi, Manh Tan Nguyen, Thanh Hien Le, Thu Hien Tran Thi, Huu Doanh Le
Hanoi Medical University, Hanoi, Vietnam.
National Hospital of Dermatology and Venereology, Hanoi, Vietnam.
J Cosmet Dermatol. 2025 Feb;24(2):e16714. doi: 10.1111/jocd.16714. Epub 2024 Dec 16.
Research on evaluating the efficacy of non-cultured epidermal cell suspension (NCECS) combined with excimer lamps for the treatment of vitiligo is currently unavailable. This research aims to evaluate the efficacy of this combination in treating vitiligo.
A prospective, controlled study was conducted from November 2021 to January 2024. Patients with stable vitiligo were randomly assigned into groups 1 (NCECS combined with excimer lamps) or 2 (NCECS alone). All patients were followed up 18 months after the procedure. Treatment effectiveness and adverse events were recorded.
Sixty patients were randomly assigned to groups 1 (30 patients) and 2 (30 patients). A total of 33.3% of patients in group 1 achieved 100% repigmentation, significantly higher than the 6.7% in group 2 (p-value = 0.021). Meanwhile, 63.3% of patients in group 1 achieved ≥ 90% repigmentation, higher than the 50% in group 2 but not statistically significant (p-value = 0.435). The mean time to initial repigmentation in group 1 (2.35 ± 0.575 weeks) was significantly shorter than in group 2 (2.72 ± 0.665 weeks) (p-value = 0.003). Both groups demonstrated a similar rate of good color match, but group 1 exhibited a lower incidence of the halo phenomenon. A total of 23.3% of patients in group 1 experienced mild erythema, which spontaneously resolved in a few days.
The combination of NCECS and excimer lamps can substantially stimulate the onset of repigmentation and enhance 100% repigmentation compared to NCECS monotherapy. Excimer lamps may reduce the incidence of the halo phenomenon.
目前尚无关于评估非培养表皮细胞悬液(NCECS)联合准分子灯治疗白癜风疗效的研究。本研究旨在评估这种联合疗法治疗白癜风的疗效。
2021年11月至2024年1月进行了一项前瞻性对照研究。将稳定期白癜风患者随机分为第1组(NCECS联合准分子灯)或第2组(仅使用NCECS)。所有患者在治疗后随访18个月。记录治疗效果和不良事件。
60例患者被随机分为第1组(30例患者)和第2组(30例患者)。第1组中共有33.3%的患者实现了100%复色,显著高于第2组的6.7%(p值 = 0.021)。同时,第1组中63.3%的患者实现了≥90%复色,高于第2组的50%,但差异无统计学意义(p值 = 0.435)。第1组首次复色的平均时间(2.35 ± 0.575周)显著短于第2组(2.72 ± 0.665周)(p值 = 0.003)。两组的颜色匹配良好率相似,但第1组的晕轮现象发生率较低。第1组共有23.3%的患者出现轻度红斑,数天内自行消退。
与NCECS单一疗法相比,NCECS联合准分子灯可显著促进复色的发生并提高100%复色率。准分子灯可能会降低晕轮现象的发生率。